|
DK200401498A
|
|
New DNA segment - has gene encoding human tissue factor heavy chain protein and is useful for inhibiting coagulation
|
|
FI970978A0
|
|
Phosphene oxide-terminated allenic molecules cleaving DNA and a method for cleaving DNA
|
|
US5912231A
|
|
Substitution analogues of magainin peptides
|
|
US5362854A
|
|
Factor VIII coagulant polypeptides: method of making
|
|
FI925026A
|
|
Mellanprodukter vid framstaellning av kalicheamicin- och esperamicinoligosackarider
|
|
FI925027A0
|
|
Proteiner som binder metall
|
|
US5265030A
|
|
System and method for determining three-dimensional structures of proteins
|
|
US5248611A
|
|
Stereoisomer separation method using antibody combing site-containing molecules
|
|
PH30491A
|
|
Molecules with antibody combining sites that exhibit catalytic properties
|
|
WO9202522A1
|
|
Dynemicin analogs: syntheses, methods of preparation and use
|
|
IE912528A1
|
|
Inhabition of mac-1 receptor binding fibrinogen using d30¹homologs
|
|
DK136491D0
|
|
Molecule with antibody combining places that expect stereospecific catalysis
|
|
US5214033A
|
|
Factor VIII coagulant polypeptides
|
|
IE911922A1
|
|
Apo ai polypeptides, diagnostic methods and systems for¹quantifying apo ai, and therapeutic methods
|
|
PT97632A
|
|
Process of obtaining polyepeptides related to hepatitis b virus surveillance antigen protein and vaccines that contain them
|
|
PT97601A
|
|
Process for preparation of intermediaries of oligosaccharides of calicheamycin and esperamycin
|
|
AU7794191A
|
|
Intermediates in the formation of the calicheamicin and esperamicin oligosaccharides
|
|
US5136030A
|
|
Immunostimulating guanine derivatives, compositions and methods
|
|
IE911347A1
|
|
System and method for determining three-dimensional¹structures of proteins
|
|
US5278299A
|
|
Method and composition for synthesizing sialylated glycosyl compounds
|
